These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 7969041)

  • 1. Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen.
    Lee JS; Paull K; Alvarez M; Hose C; Monks A; Grever M; Fojo AT; Bates SE
    Mol Pharmacol; 1994 Oct; 46(4):627-38. PubMed ID: 7969041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DiOC2(3) is not a substrate for multidrug resistance protein (MRP)-mediated drug efflux.
    Minderman H; Vanhoefer U; Toth K; Yin MB; Minderman MD; Wrzosek C; Slovak ML; Rustum YM
    Cytometry; 1996 Sep; 25(1):14-20. PubMed ID: 8875050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposome composition is important for retention of liposomal rhodamine in P-glycoprotein-overexpressing cancer cells.
    Kang DI; Kang HK; Gwak HS; Han HK; Lim SJ
    Drug Deliv; 2009 Jul; 16(5):261-7. PubMed ID: 19538007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of a drug resistance profile by quantitation of mdr-1/P-glycoprotein in the cell lines of the National Cancer Institute Anticancer Drug Screen.
    Alvarez M; Paull K; Monks A; Hose C; Lee JS; Weinstein J; Grever M; Bates S; Fojo T
    J Clin Invest; 1995 May; 95(5):2205-14. PubMed ID: 7738186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-drug resistance (MDR) activity in acute leukemia determined by rhodamine 123 efflux assay.
    Lamy T; Drenou B; Grulois I; Fardel O; Jacquelinet C; Goasguen J; Dauriac C; Amiot L; Bernard M; Fauchet R
    Leukemia; 1995 Sep; 9(9):1549-55. PubMed ID: 7658724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzquinamide inhibits P-glycoprotein mediated drug efflux and potentiates anticancer agent cytotoxicity in multidrug resistant cells.
    Mazzanti R; Croop JM; Gatmaitan Z; Budding M; Steiglitz K; Arceci R; Arias IM
    Oncol Res; 1992; 4(8-9):359-65. PubMed ID: 1362504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of hypotonic and hypoionic media on drug pumping by P-glycoprotein expressed in epithelial and nonepithelial cell lines.
    Ambasch K; Cabantchik ZI; Slotki IN
    J Cell Physiol; 1995 Jul; 164(1):117-22. PubMed ID: 7790383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rhodamine 123: is it an appropriate dye to study P-glycoprotein activity in adriamycin-resistant K562 cells?
    Denis-Gay M; Petit JM; Ratinaud MH
    Anticancer Res; 1995; 15(1):121-6. PubMed ID: 7733620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells.
    Sachs-Barrable K; Thamboo A; Lee SD; Wasan KM
    J Pharm Pharm Sci; 2007; 10(3):319-31. PubMed ID: 17727795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of different chemicals on MDR-1 P-glycoprotein expression and activity in the HK-2 proximal tubular cell line.
    Romiti N; Tramonti G; Chieli E
    Toxicol Appl Pharmacol; 2002 Sep; 183(2):83-91. PubMed ID: 12387747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of vinblastine, colchicine, and verapamil on rhodamine 123 accumulation in human P-glycoprotein-positive leukemia cells.
    Lautier D; Canitrot Y; Salmon JM
    Anticancer Res; 1994; 14(6B):2589-95. PubMed ID: 7872686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.
    Li X; Sun B; Zhu CJ; Yuan HQ; Shi YQ; Gao J; Li SJ; Lou HX
    Toxicol In Vitro; 2009 Feb; 23(1):29-36. PubMed ID: 18938236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of P-glycoprotein-mediated multidrug resistance by flavonoid derivatives and analogues.
    Hadjeri M; Barbier M; Ronot X; Mariotte AM; Boumendjel A; Boutonnat J
    J Med Chem; 2003 May; 46(11):2125-31. PubMed ID: 12747785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of P-glycoprotein-mediated multidrug resistance by acceleration of passive drug permeation across the plasma membrane.
    Regev R; Katzir H; Yeheskely-Hayon D; Eytan GD
    FEBS J; 2007 Dec; 274(23):6204-14. PubMed ID: 17986257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of multidrug resistance to rhodamine-123 selectivity between carcinoma and normal epithelial cells: taxol and vinblastine modulate drug efflux.
    Brouty-Boyé D; Kolonias D; Wu CJ; Savaraj N; Lampidis TJ
    Cancer Res; 1995 Apr; 55(8):1633-8. PubMed ID: 7712466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of beta-adrenergic antagonists, H1-receptor blockers, analgesics, diuretics, and quinolone antibiotics on the cellular accumulation of the anticancer drug, daunorubicin: P-glycoprotein modulation.
    Ibrahim S; Peggins J; Knapton A; Licht T; Aszalos A
    Anticancer Res; 2001; 21(2A):847-56. PubMed ID: 11396174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug resistance reversal in mouse lymphoma cells by heterocyclic compounds.
    Molnár J; Szabo D; Mándi Y; Mucsi I; Fischer J; Varga A; König S; Motohashi N
    Anticancer Res; 1998; 18(4C):3033-8. PubMed ID: 9713505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric assessment of the cellular pharmacokinetics of fluorescent drugs.
    Dordal MS; Ho AC; Jackson-Stone M; Fu YF; Goolsby CL; Winter JN
    Cytometry; 1995 Aug; 20(4):307-14. PubMed ID: 7587718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topological folding and proteolysis profile of P-glycoprotein in membranes of multidrug-resistant cells: implications for the drug-transport mechanism.
    Zhang M; Wang G; Shapiro A; Zhang JT
    Biochemistry; 1996 Jul; 35(30):9728-36. PubMed ID: 8703944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of P-glycoprotein transport function and reversion of MDR1 multidrug resistance by cnidiadin.
    Barthomeuf C; Grassi J; Demeule M; Fournier C; Boivin D; Béliveau R
    Cancer Chemother Pharmacol; 2005 Aug; 56(2):173-81. PubMed ID: 15824923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.